Concepedia

Myron S. Ignatius

MS

Statistics

Publications

23

Citations

1.4K

H-Index

20

Active since

2007

Affiliations

Massachusetts General Hospital(Current)

Harvard Stem Cell Institute

Center for Cancer Research

Harvard University

University of Washington

Myron S. Ignatius is an author at Massachusetts General Hospital specializing in oncology, molecular oncology, and life sciences.

ORCID

Publications per year

2007–2023

23

Publications

23

Glycogen synthase kinase 3 inhibitors induce the canonical WNT/β-catenin pathway to suppress growth and self-renewal in embryonal rhabdomyosarcoma

Eleanor Y. Chen, Michael DeRan, Myron S. Ignatius et al. · Proceedings of the National Academy of Sciences · 2014 · 151 citations · Full text

, , +17

Optimized cell transplantation using adult rag2 mutant zebrafish

Qin Tang, Nouran S. Abdelfattah, Jessica S. Blackburn et al. · Nature Methods · 2014 · 145 citations · Full text

, , +11

High-throughput cell transplantation establishes that tumor-initiating cells are abundant in zebrafish T-cell acute lymphoblastic leukemia

Alexandra Smith, Aubrey R. Raimondi, Chris D. Salthouse et al. · Blood · 2010 · 134 citations · Full text

, , +15

In Vivo Imaging of Tumor-Propagating Cells, Regional Tumor Heterogeneity, and Dynamic Cell Movements in Embryonal Rhabdomyosarcoma

Myron S. Ignatius, Eleanor Y. Chen, Natalie Elpek et al. · Cancer Cell · 2012 · 113 citations · Full text

, , +17

Imaging tumour cell heterogeneity following cell transplantation into optically clear immune-deficient zebrafish

Qin Tang, John C. Moore, Myron S. Ignatius et al. · Nature Communications · 2016 · 90 citations · Full text

, , +17

1–5 of 23